Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s Oncology Divisions Have Been Providing Live Meeting Minutes For Years. Will Others Follow?

Jul 12 2023

• By Derrick Gingery

Meeting minutes — Providing live meeting minutes may be a difficult policy to implement outside the oncology review divisions. • Source: Shutterstock

Related Content

Moderna’s COVID-19 Vaccine To Get Real-Time Data Assessment By US FDA

Jul 28 2020

Candidates For The US FDA’s STAR Program Might As Well Be Breakthrough Therapies, Too

Jun 27 2022

For Cell And Gene Therapies, Expedited Designation And Complex Questions Improve FDA Meeting Chances

Jun 03 2022

US FDA’s PDUFA VIII Ideas Could Include Creating Regulatory Science Research Program

Jun 10 2023

Supplemental Filings: FDA Expands In-Person Meeting Eligibility Again; Marks Suggests Sponsors Invite Foreign Regulators To FDA Meetings

Jun 03 2023

US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?

Oct 04 2022

US FDA's Oncology Division Wants To Know About Your Pipeline, Not Just Your NDAs

Nov 20 2017

Related Companies

Janssen R&D LLC

Pfizer Inc.

Additional Topics

United States Research & Development Review Pathway Regulation User Fees BioPharmaceutical

More from R&D

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window